Medtronic
MDT
2,060 hedge funds and large institutions have $112B invested in Medtronic in 2021 Q4 according to their latest regulatory filings, with 264 funds opening new positions, 856 increasing their positions, 740 reducing their positions, and 196 closing their positions.
35% more first-time investments, than exits
New positions opened: 264 | Existing positions closed: 196
16% more repeat investments, than reductions
Existing positions increased: 856 | Existing positions reduced: 740
2% more funds holding
Funds holding: 2,024 → 2,060 (+36)
3% more call options, than puts
Call options by funds: $1B | Put options by funds: $978M
0.22% more ownership
Funds ownership: 80.28% → 80.5% (+0.22%)
35% less funds holding in top 10
Funds holding in top 10: 55 → 36 (-19)
38% less capital invested
Capital invested by funds: $180B → $112B (-$68.1B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$603M |
| 2 |
BlackRock
New York
|
+$565M |
| 3 |
Renaissance Technologies
New York
|
+$361M |
| 4 |
D.E. Shaw & Co
New York
|
+$291M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$265M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$632M |
| 2 |
JP Morgan Chase
New York
|
-$533M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$384M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$306M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$304M |
MDT Hedge Fund Activity: Q4 2021 in Review
2,060 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q4 2021, worth a combined $112B — down 38% from $180B a quarter earlier.
Buyers outnumbered sellers: 264 funds opened new MDT positions and 196 closed out — a net gain of 68 holders — while 856 added to existing stakes and 740 trimmed.
The largest buyer was Franklin Resources, adding an estimated $603M. The largest seller was DZ Bank, cutting an estimated $632M.
- 2,060 institutional investors held Medtronic (MDT) as of Q4 2021, up from 2,024 in Q3 2021.
- Funds reported $112B of Medtronic stock for Q4 2021, down 38% quarter-over-quarter.
- 264 funds opened new Medtronic positions in Q4 2021 and 196 closed out, a net change of +68 holders.
- The largest Medtronic buyer in Q4 2021 was Franklin Resources, an estimated $603M added.
- The largest Medtronic seller in Q4 2021 was DZ Bank, an estimated $632M sold.
Based on aggregated 13F filings for Q4 2021.